Selank administration affects the expression of some genes involved in GABAergic neurotransmission
Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, Slominsky P
Frontiers in Pharmacology (2016) · n=30
Forty-five genes changed expression 1 hour after a single intranasal 300 µg/kg dose of Selank in rat frontal cortex, with strong positive correlation (r=0.86) to GABA's own effect pattern; by 3 hours, Selank uniquely drove a 128-fold increase in hypocretin (Hcrt) expression — a candidate explanation for why Selank does not produce the sedation that benzodiazepines do.
The contemporary molecular re-framing of Selank's mechanism, by the Institute of Molecular Genetics (Russian Academy of Sciences) group that originally synthesized the peptide. Unlike the Kost 2001 and Sokolov 2002 opioidergic-mechanism papers, this 2016 study takes the alternative GABAergic hypothesis seriously and tests it directly at the level of gene expression.
Thirty male Wistar rats (n=10 per group) received a single intranasal dose of either Selank (300 µg/kg in 6 µL deionized water), GABA at the same volume / concentration, or vehicle. Frontal cortex was dissected at 1 hour or 3 hours post-administration and analysed by custom RT² Profiler PCR array for 84 genes involved in GABAergic, dopaminergic, serotonergic, and related neurotransmission pathways.
At 1 hour, Selank changed expression of 45 genes; 25 of these were also changed by GABA (Pearson's r = 0.86 between the Selank and GABA expression patterns, p≤0.05), and 4 were uniquely affected by Selank (Drd1a, Drd2, Ptgs2, Slc6a13). At 3 hours, the pattern diverged sharply: Selank uniquely changed 13 genes, including a 128-fold increase in hypocretin (Hcrt) expression, 16-fold and 13-fold increases in the GABA-A receptor subunits epsilon (Gabre) and theta (Gabrq) respectively, and a 3.2-fold increase in adenylate cyclase 7 (Adcy7).
The authors interpret Selank as a positive allosteric modulator of the GABAergic system whose downstream gene-expression signature is GABA-like at 1 hour but distinctively Selank-specific at 3 hours, with the late hypocretin upregulation a candidate explanation for why Selank produces an anxiolytic effect without the sedation that benzodiazepines produce.
The study examined a single brain region (frontal cortex), two time-points (1 and 3 hours), and a fixed gene panel (84 genes) — it cannot detect Selank effects on other brain regions, time-courses outside this window, or genes outside the panel. Sample size is small (n=10 per group, tissues pooled for the array, with half decapitated at 1 hour and half at 3 hours, leaving n=5 per group per time-point). Only male rats were studied.
The gene-expression read-out is a downstream signal — it does not directly demonstrate that Selank binds GABA-A receptors or that the expression changes are necessary or sufficient for the behavioural effect. The 1-hour positive correlation with GABA (r=0.86) is consistent with the positive-allosteric-modulator hypothesis but is also consistent with alternative mechanisms.
The 128-fold Hcrt upregulation at 3 hours is striking but is single-time-point single-region single-modality data; whether this translates to changes in hypocretin protein levels, neuronal firing, or behavioural arousal is not tested. Note this paper is originally in English (open-access Frontiers); no translation step was required for this entry.
07·Member discussion
No member discussion yet.
Member-only conversation lives here — cycle notes, practitioner commentary, pattern-matching. Be the first paying member to start the thread.